Harnessing T Cells To Detect Disease : vimarsana.com

Harnessing T Cells To Detect Disease


Science Writer
Adaptive Biotechnologies recently received FDA Emergency Use Authorization (EUA) for T-Detect™ COVID, a test that detects the unique T-cell signature specific to SARS-CoV-2. T-Detect COVID is the first clinical test launched from Adaptive’s TCR-Antigen Map collaboration with Microsoft, highlighting the potential of using T cells in the blood to detect multiple diseases.
To learn more about T-Detect, its development and how it compares to antibody testing,
Technology Networks spoke to Dr Sudeb Dalai, senior medical director at Adaptive Biotechnologies. In this interview, Sudeb also discusses the role that T-cell analysis may play in the diagnosis and treatment of diseases in the future.  

Related Keywords

Sudeb Dalai , Technology Networks , Microsoft , Adaptive Biotechnologies , Use Authorization , Antigen Map , தொழில்நுட்பம் நெட்வொர்க்குகள் , மைக்ரோசாஃப்ட் , மாற்றி அமைக்கத்தக்க உயிரி தொழில்நுட்பங்கள் , பயன்பாடு அங்கீகாரம் ,

© 2025 Vimarsana